ALPMF
ASTELLAS PHARMA INC
stockOTC

EODNov 13, 2026

17.32USD+4.653%(+0.77)1,029

Loading…

Market Cap

29.95B

Sector

Healthcare

Industry

Drug Manufacturers-General

Tokyo, Tokyo To, Japan

Employees

14,484

Previous Close

$15.96

Beta

0.71

52-Week High

$18.03 2026-11-03

52-Week Low

$11.40 2025-11-24

SMA 50

$15.61

SMA 200

$14.50

Avg. Vol 10D

2,931

Avg. Vol 30D

3,702

Avg. Vol 90D

6,941

Relative Vol

1.17

1.81B

1.71B

4,810,405

0.28%

999.99

Nov 13, 2026

04:23 PM ESTAstraZeneca gains additional bladder cancer indication for Imfinzi ·

Seeking Alpha

Nov 12, 2026

08:40 AM ESTAstellas, Immuneering Enter Pancreatic Cancer Trial Collaboration ·

RTTNews

Nov 5, 2026

08:01 PM ESTQ2 2027 Astellas Pharma Inc. Earnings Presentation Transcript ·

GuruFocus

Nov 4, 2026

02:57 AM ESTAstellas Pharma (ALPMY) Reports Strong H1 Results, Dividend Sustainability in Focus ·

GuruFocus

02:38 AM ESTAstellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook ·

Seeking Alpha

ALPMF Performance

Period	Price	Date	Change	Beta
1W	16.00	2026-11-06	+3.44%	-2.229
1M	13.10	2026-10-13	+26.34%	0.908
3M	13.45	2026-08-13	+23.05%	0.960
6M	14.45	2026-05-13	+14.53%	1.385
1Y	12.20	2025-11-14	+35.66%	0.708
2Y	11.10	2024-11-12	+49.17%	—
5Y	17.15	2021-11-15	-3.50%	-0.176

ALPMF Stock Summary

ASTELLAS PHARMA INC (OTC:ALPMF) stock price today is $16.55, and today's volume is 4,349. ALPMF is up 3.697% today. The 30 day average volume is 3,702. ALPMF market cap is $29.95B with 1.81B shares outstanding.

ALPMFASTELLAS PHARMA INCstockOTC

ALPMF
ASTELLAS PHARMA INC
stockOTC